Press Archive
- Charles Francis: Weakening eye surgery laws places WV patients in jeopardy
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Details
In their recent article, Watanabe et al1 explored relationships between corneal guttae and visual function in eyes with “mild” Fuchs' endothelial corneal dystrophy (FECD).1 They concluded that guttae affect quality of vision (QOV), and that “early endothelial keratoplasty for patients with mild FECD without severe edema should be considered to remove corneal guttae that affect the QOV parameters.”
- Details
Over the last decade, nonsteroidal anti-inflammatory drugs (NSAIDs) have been used increasingly in the setting of cataract surgery. Despite overwhelming acceptance of this practice, there is a paucity of data that clearly demonstrates the effectiveness of NSAIDs in improving long-term visual outcomes. According to a survey in 2012 by the American Society of Cataract and Refractive Surgery, 90% of its membership routinely prescribes an NSAID in addition to, but not as a replacement for, a corticosteroid during cataract surgery at a cost of nearly $200 per brand prescription and amounting to an annual societal cost approximating $540 million.
- Details
To investigate the efficacy of intravitreal injection of recombinant tissue plasminogen activator (rt-PA), ranibizumab, and gas without vitrectomy for submacular hemorrhage.
- Details
To elucidate the temporal relationship between detection of glaucomatous optic disc progression, as assessed by fundus photography, and visual field progression.
Read more: Structural and Functional Progression in the Early Manifest Glaucoma Trial
- Details
To compare diabetic retinopathy (DR) identification and ungradable image rates between nonmydriatic ultrawide field (UWF) imaging and nonmydriatic multifield fundus photography (NMFP) in a large multistate population-based DR teleophthalmology program.